Home / Cancer and immune system / Fingolimod
ATC L04AE01 · Sphingosine-1-Phosphate (S1P) Receptor Modulators · updated 4 Nov 2026
Fingolimod shortage
As of 4 Nov 2026, Fingolimod has a reported shortage in 9 of the 16 countries we track (Canada, Germany, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden), covering 23 products from 10 companies.
Is there a Fingolimod shortage?
Yes. As of 4 Nov 2026, Fingolimod is reported short in 9 of the 16 countries we track: Canada, Germany, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden. The earliest expected return is 22 Nov 2026 (Spain). 9 of 23 affected products have no return date. New since 5 Oct 2026: Spain, Norway.
spreading How the shortage spread
All cross-border shortagesCountries in the order the shortage started there (earliest start date of a product still short). First reported in Canada on 4 Mar 2022; most recently in Norway on 26 Oct 2026.
- CACanadasince 4 Mar 2022
- SESwedensince 13 Dec 2023
- ESSpainsince 31 Mar 2024
- CZCzechiasince 3 Nov 2025
- IEIrelandsince 19 Dec 2025
- DEGermanysince 1 Jun 2026
- ITItalysince 5 Jun 2026
- ATAustriasince 13 Aug 2026
- NONorwaysince 26 Oct 2026
Not on the official list in: United States, France, Belgium, Switzerland, Japan, New Zealand, Australia.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Viatris VTRS · Nasdaq, Aurobindo AUROPHARMA · NSE, Teva TEVA · NYSE / TASE, Glenmark GLENMARK · NSE
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACH-FINGOLIMOD (28) | ACCORD HEALTHCARE INC | 4 Mar 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-FINGOLIMOD (28 BLS) | APOTEX INC | 7 May 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-FINGOLIMOD (28BL) | MYLAN PHARMACEUTICALS ULC | 7 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| DE | Fingolimod PUREN 0,5 mg Hartkapseln | PUREN Pharma GmbH & Co. KG | 1 Jun 2026 | 30 Jan 2027 | Manufacturing problem Probleme bei der Endfreigabe |
| DE | Fingolimod Zentiva 0,5 mg Hartkapseln | Zentiva Pharma GmbH | 1 Sep 2026 | 8 Jan 2027 | Other Probleme bei der Chargenprüfung |
| DE | Fingolimod Zentiva 0,5 mg Hartkapseln | Zentiva Pharma GmbH | 1 Sep 2026 | 8 Jan 2027 | Other Probleme bei der Chargenprüfung |
| IT | FINGOLIMOD ZENTIVA | ZENTIVA ITALIA S.R.L. | 5 Jun 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LOGNIF | TEVA ITALIA S.R.L. | 30 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | FINGOLIMOD ACCORD 0,5 mg CAPSULAS DURAS EFG, 28 cápsulas | Accord Healthcare S.L.U. | 31 Mar 2024 | 30 Mar 2027 | Not stated |
| ES | FINGOLIMOD GLENMARK 0,5 MG CAPSULAS DURAS EFG 28 capsulas | Glenmark Arzneimittel Gmbh | 11 Feb 2026 | 30 Dec 2026 | Not stated |
| ES | FINGOLIMOD TARBIS 0,25 mg CAPSULAS DURAS EFG, 28 capsulas | Tarbis Farma S.L. | 22 Feb 2026 | not given | Not stated |
| ES | LOGNIF 0,25 MG CAPSULAS DURAS EFG, 28 cápsulas (Blister OPA/AL/PVC//Al) | Teva Gmbh | 3 Mar 2026 | 7 Jan 2027 | Not stated |
| ES | FINGOLIMOD ZENTIVA 0,5 MG CAPSULAS DURAS EFG, 28 cápsulas | Zentiva K.S. | 28 Jun 2026 | 29 Nov 2026 | Not stated |
| ES | FINGOLIMOD AUROVITAS 0,5 MG CAPSULAS DURAS EFG, 28 cápsulas | Aurovitas Spain, S.A.U. | 29 Oct 2026 | 22 Nov 2026 | Not stated |
| IE | Fingolimod Clonmel 0.5 mg hard capsules | Clonmel Healthcare Ltd | 19 Dec 2025 | not given | Manufacturing problem Manufacturing delay |
| AT | Fingolimod Zentiva 0,5 mg Hartkapseln, 28 Stück | Zentiva k.s. | 13 Aug 2026 | not given | Quality problem or recall Qualitätsprobleme des Fertigproduktes |
| AT | Fingolimod Zentiva 0,5 mg Hartkapseln, 7 Stück | Zentiva k.s. | 13 Aug 2026 | not given | Quality problem or recall Qualitätsprobleme des Fertigproduktes |
| CZ | FINGOLIMOD GLENMARK 0,5MG 0,5MG CPS DUR 28 | Glenmark Pharmaceuticals s.r.o., Praha | 3 Nov 2025 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| NO | Fingolimod Zentiva 0,5 mg kapsel, hard, 28 stk blisterpakning | Zentiva k.s. | 26 Oct 2026 | 27 Nov 2026 | Quality problem or recall Kvalitetsproblemer |
| SE | Fingolimod Accord 0,5 mg Blister, 28 x 1 kapslar (endos) | Accord Healthcare S.L.U. | 13 Dec 2023 | 30 Jun 2027 | Not stated |
| SE | Fingolimod Mylan 0,5 mg Blister, 28 kapslar (PVC/PE/PVdC-Alu) | Mylan Pharmaceuticals Limited | 28 Jul 2025 | 1 Mar 2027 | Not stated |
| SE | Fingolimod Glenmark 0,5 mg Blister, 28 kapslar | Glenmark Pharmaceuticals Nordic AB | 24 Apr 2026 | 25 Mar 2027 | Not stated |
| SE | Fingolimod Teva 0,5 mg Blister, 28 kapslar anticipated | TEVA GmbH | 28 Dec 2026 | 31 Aug 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Fingolimod shortage?
Yes. As of 4 Nov 2026, Fingolimod is reported short in 9 of the 16 countries we track: Canada, Germany, Italy, Spain, Ireland, Austria, Czechia, Norway, Sweden. The earliest expected return is 22 Nov 2026 (Spain). 9 of 23 affected products have no return date. New since 5 Oct 2026: Spain, Norway.
When will Fingolimod be back in stock?
Companies expect supply back from 22 Nov 2026 in Spain; Canada: no date given; Germany: 8 Jan 2027; Italy: no date given; Spain: 22 Nov 2026; Ireland: no date given; Austria: no date given; Czechia: 31 Dec 2026; Norway: 27 Nov 2026; Sweden: 1 Mar 2027. These are company estimates reported to each authority.
Why is Fingolimod in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Fingolimod shortages?
Zentiva, Accord (Intas), Teva, Glenmark, Viatris, Apotex, Aurobindo, Tarbis Farma, Aurovitas Spain, Stada.